1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Longduoduo Company Limited

Longduoduo Company Limited

LDDD
Longduoduo Company LimitedUS flagOther OTC
0.93
USD
+0.42
- -
28.03MMarket Cap
Longduoduo Company Limited
LDDD
(Other OTC)

Recent

price

0.93

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
FRC
0.01
0.11
0.13
0.25
0.14
0.07
Revenue per Share
-0.01
-0.25
- -
0.04
0.02
-0.01
Basic EPS, GAAP
0.01
- -
0.03
0.01
0.01
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
-0.26
-0.26
-0.22
-0.2
-0.22
Book Value per Share
-0.01
-0.03
-0.02
0.03
0.04
0.03
Tangible Book Value per Share
30
30
30
30
30
30
Basic Weighted Avg Shares
- -
3
4
7
4
2
Sales/Revenue/Turnover
-91.44
-233.33
0.77
27.42
12.97
-20.17
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-8
- -
1
- -
- -
Net Income, GAAP
- -
- -
32.7
27.73
31.11
40.98
Effective Tax Rate (%)
-79.4
-232.16
-1.02
16.99
10.8
-16.54
Profit Margin (%)
-1
-1
-1
- -
1
1
Working Capital
- -
- -
- -
- -
- -
- -
LT Debt
- -
-1
-1
1
1
1
Total Equity
- -
- -
- -
1,128.05
35.73
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
30
30
Market Capitalization
33
18
15

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
2
2
1
Cash, Cash Equivalents & STI
1
2
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
65.98%
Free Cash Flow
- -
- -
-21.24%
Net Income, GAAP
- -
- -
-63.33%
Sales/Revenue/Turnover
- -
- -
-42.32%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
2
2
2
7
2025
1
2
1
1
4
2026
1
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
0.02
- -
0.04
2025
- -
0.02
- -
- -
0.02
2026
- -
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Genetron Holdings Limited (GTH)
Myriad Genetics, Inc. (MYD.DE)
Cellbxhealth PLC (ANPCF)
Medivolve Inc. (4NC.F)
Devyser Diagnostics AB (publ) (DVYSR.ST)
Thyrocare Technologies Limited (THYROCARE.BO)
Business
There is no specific publicly available information found regarding recent major company changes for Longduoduo Company Limited (Ticker: LDDD) such as partnerships, strategic alliances, funding rounds, acquisitions, new product launches, or name changes in the last 1-2 years. The company is known for its core business operations, which include e-commerce, online retail, and associated services. If you want, I can provide a professional company description based on typical financial database standards by focusing on the known core business, products, services, geographic operations, founding year, headquarters, and market segments for Longduoduo Company Limited, with a relevant formal corporate tone. Please confirm.